FSIDX
Price
$17.71
Change
+$0.08 (+0.45%)
Updated
Jul 3 closing price
Net Assets
5.21B
JAVAX
Price
$15.00
Change
+$0.09 (+0.60%)
Updated
Jul 3 closing price
Net Assets
26.1M
Interact to see
Advertisement

FSIDX vs JAVAX

Header iconFSIDX vs JAVAX Comparison
Open Charts FSIDX vs JAVAXBanner chart's image
Fidelity Advisor Strategic Div & Inc I
Price$17.71
Change+$0.08 (+0.45%)
VolumeN/A
Net Assets5.21B
James Aggressive Allocation
Price$15.00
Change+$0.09 (+0.60%)
VolumeN/A
Net Assets26.1M
FSIDX vs JAVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSIDX vs. JAVAX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSIDX is a Buy and JAVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSIDX has more cash in the bank: 5.21B vs. JAVAX (26.1M). FSIDX pays higher dividends than JAVAX: FSIDX (2.42) vs JAVAX (0.64). FSIDX was incepted earlier than JAVAX: FSIDX (22 years) vs JAVAX (10 years). JAVAX (1.02) is less costly to investors than FSIDX (0.67). FSIDX is a more actively managed with annual turnover of: 36.00 vs. JAVAX (19.00). FSIDX has a lower initial minimum investment than JAVAX: FSIDX (0) vs JAVAX (10000). JAVAX annual gain was more profitable for investors over the last year : 10.60 vs. FSIDX (8.73). JAVAX return over 5 years is better than : 66.37 vs. FSIDX (37.68).
FSIDXJAVAXFSIDX / JAVAX
Total Expense Ratio0.671.0266%
Annual Report Gross Expense Ratio0.671.0266%
Fund Existence22 years10 years-
Gain YTD5.7135.520103%
Front LoadN/AN/A-
Min. Initial Investment010000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.21B26.1M19,954%
Annual Yield % from dividends2.420.64378%
Returns for 1 year8.7310.6082%
Returns for 3 years21.9754.6040%
Returns for 5 years37.6866.3757%
Returns for 10 years48.2360.9179%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FACTX48.07N/A
N/A
Fidelity Advisor Health Care M
BAFAX43.24N/A
N/A
Brown Advisory Flexible Equity Adv
IRSAX14.99N/A
N/A
Macquarie Real Estate Securities A
DMCRX13.45N/A
N/A
Driehaus Micro Cap Growth
TRJZX112.70N/A
N/A
T. Rowe Price Growth Stock Z